+Compare
KZIA
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
14.13M

KZIA Kazia Therapeutics Limited Forecast, Technical & Fundamental Analysis

a company, which engages in the business of pharmaceutical research and development

Industry Biotechnology
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Novavax (NASDAQ:NVAX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Sorrento Therapeutics, Inc. (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.29B. The market cap for tickers in the group ranges from 402 to 464.61B. NVO holds the highest valuation in this group at 464.61B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 5%. For the same Industry, the average monthly price growth was 37%, and the average quarterly price growth was 8%. AWKNF experienced the highest price growth at 165%, while AXLA experienced the biggest fall at -76%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -21% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 85
Price Growth Rating: 59
SMR Rating: 94
Profit Risk Rating: 95
Seasonality Score: -6 (-100 ... +100)
View a ticker or compare two or three
Ad is loading...
A.I. Advisor
published General Information

General Information

a company, which engages in the business of pharmaceutical research and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Barangaroo Avenue
Phone
+61 294724101
Employees
16
Web
https://www.kaziatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMRBX4.83N/A
N/A
American Growth One B
INFIX7.56N/A
-0.04%
Tortoise Energy Infras and Inc Ins
DDDCX18.42-0.03
-0.16%
13D Activist C
FSMVX26.56-0.08
-0.30%
Fidelity® Mid Cap Value
JGMRX22.16-0.17
-0.76%
Janus Henderson Triton R

KZIA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with ALRN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then ALRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+7.02%
ALRN - KZIA
36%
Loosely correlated
+4.40%
NVO - KZIA
31%
Poorly correlated
-2.35%
RVMD - KZIA
29%
Poorly correlated
+1.75%
BTAI - KZIA
28%
Poorly correlated
+1.82%
MRNS - KZIA
28%
Poorly correlated
+0.16%
More

Groups containing KZIA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
+7.02%
biotechnology
(undefined stocks)
15%
Poorly correlated
+1.26%
drugs
(undefined stocks)
12%
Poorly correlated
+1.21%
pharmaceuticals
(undefined stocks)
7%
Poorly correlated
+1.73%
australia
(undefined stocks)
6%
Poorly correlated
+0.15%